A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT05029921 · COMPLETED
Trial details
- NCT number
- NCT05029921
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2025-05-18
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.